Xebio Holdings Co Ltd (8281) Stock Price & News

Why is 8281 down 2.63%?

Dive Deeper

8281:TYO

Xebio Holdings Co Ltd

¥1,074.00

-2.63%

(-29.00) 1D

Oct 2, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 8281...

Open

¥1,093

High

¥1,093

Low

¥1,068

Mkt. cap

51.46B

Avg. vol.

160.70K

Volume

140.80K

Dividend

3.26%

Quarterly dividend

¥9

Ex-dividend date

Sep 29, 2026

P/E ratio

128.02

52-wk high

¥1,251

52-wk low

¥951

EPS

¥8

Shares outstanding

44.33M

No. of employees

Open

¥1,093

High

¥1,093

Low

¥1,068

Mkt. cap

51.46B

Avg. vol.

160.70K

Volume

140.80K

Dividend

3.26%

Quarterly dividend

¥9

Ex-dividend date

Sep 29, 2026

P/E ratio

128.02

52-wk high

¥1,251

52-wk low

¥951

EPS

¥8

Shares outstanding

44.33M

No. of employees

Related stocks

News stories

From web sources and news partners

marketscreener.com

55 minutes ago

S&P holds Romania rating, expects credible budget framework

BigGo Finance

1 hour ago

U.S. 10-Year Yield Tops 5.3%: S&P 500 Looks Solid on the Surface, But Five Major Sectors Are Already Cracking

TradingView

1 hour ago

Nasdaq rises for the week as Lumentum leads gains

U.S. Global Investors

1 hour ago

Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500

About Xebio Holdings Co Ltd

CEO-

Employees2.45K

Founded1962

HeadquartersKoriyama, Fukushima, Japan

SectorConsumer

Websitexebio.co.jp

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	60.00B	64.50B	63.53B	68.24B
Cost of goods sold	37.85B	39.61B	41.01B	41.40B
Cost of revenue	37.85B	39.61B	41.01B	41.40B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	22.93B	24.45B	15.75B	22.89B
Operating expense	22.93B	24.45B	22.40B	22.89B
Total operating expenses	60.78B	64.06B	63.41B	64.29B
Operating income	-784.00M	439.00M	119.00M	3.95B
Other non operating income	220.00M	457.00M	37.00M	255.00M
EBT including unusual items	-296.00M	1.13B	-3.98B	4.23B
EBT excluding unusual items	-70.00M	1.22B	549.00M	4.20B
Income tax expense	-66.00M	434.00M	-805.00M	1.40B
Effective tax rate	22.30%	38.54%	20.24%	33.12%
Other operating expenses	-	-	-	-
Net income	-122.00M	700.00M	-3.03B	2.82B
Net profit margin	-0.20%	1.09%	-4.77%	4.13%
Earnings per share	-	-	-	-
Interest and investment income	21.00M	10.00M	-	37.00M
Interest expense	-25.00M	-25.00M	-31.00M	-53.00M
Net interest expenses	-4.00M	-15.00M	-31.00M	-16.00M
Depreciation and amortization charges	-	-	6.49B	-
EBITDA	763.00M	-	1.86B	5.69B
Gain or loss from assets sale	-	-	-	-

Ask anything